Improving the cost and speed of clinical trials has been a long time coming. While plenty of hurdles remain, Radicle Science is doing it – all the while maintaining scientific rigor and bettering the generalizability of the findings.
This round-up will feature scientific findings from big brand names, including Swisse and its study of krill oil supplementation on knee osteoarthritis, Amway’s personalised nutrition, and India’s national research agency’s plans for studying cannabidiol...
With consumers increasingly demanding scientifically-validated nutra products and ingredients, one of the key scientists in Australia’s national research agency has revealed the three factors that are crucial for a high-quality trial.
A FANCL-funded RCT study has discovered that the ingestion of tea flower extract, mulberry leaf extract, and chitosan could reduce postprandial blood glucose and triglyceride levels in healthy subjects.
Clinical trials involving diet are severely under-funded and more difficult to complete than drugs studies, say researchers who warn that nutrition studies are prone to bias, are often too small and of too short duration and regularly change outcome...
A growing number of clinical studies focusing on probiotics is seen in Asia, with China and Iran seeing exponential increase in recent years, according to an International Probiotics Association-backed review.
DSM has entered a regional agreement with SLS Nutraceuticals, a subsidiary of biotechnology company Senescence Life Sciences, in a bid to improve brain health across all life stages in the Asia-Pacific region.
Qatar University researchers are conducting an RCT to assess the effectiveness of protein supplementation in lowering the risk of protein malnutrition and muscle wasting in post-bariatric surgery patients.
A new study on Natreon’s AyuFlex botanical ingredient shows decreased joint pain and increased mobility among a study population of overweight adults. It’s part of the company’s strategy to support entry into new markets with hard data on its ingredients.
What can pharmaceutical and nutrition industries learn from each other, and is the historical divide between the two slowly starting to be bridged? In this special edition article we look at how the two worlds of pharma and nutrition are colliding.
In a systematic review, researchers in Brazil concluded that with the science available, “it would not be appropriate to recommend, at the moment”, the clinical use of prebiotics, or its combination with probiotics, to tackle obesity-related health risks.
Daily supplements containing Rhodiola rosea extract may improve the symptoms of burnout, suggests data from the first trial to examine the effects of the botanical extract on this modern day condition.
Restrictions on word counts in scientific journals on the reporting of trials on the efficacy of supplements can hinder the quality of the reporting of the study, according to the author of a study which judged the quality of reporting to be “poor”.
The need for robust research to validate health claims for a food ingredient has never been in doubt. But with regulations becoming ever more stringent the role of Contract Research Organisations (CROs) appears to be changing.
Development of products with urolithin A, a metabolite from pomegranate compounds, took a big step forward as scientists reported results from a Phase 1 trial supporting the safety, bioavailability, and biological activity of the compound.
Having quickly established its credentials in the sports nutrition space, positive results in recent clinical trials are creating new opportunities for Nutrition 21’s Nitrosigine in the cognitive health sector.
Development of an in vitro model that mimics the gastrointestinal tract is one of the ways in which Biofortis and Triskelion hope to help further research into the relationship between the gut microbiome and immune health, under a new partnership.
Soy supplements may reduce the risk of cardiovascular risk for people able to produce equol, a microbial-derived metabolite of the isoflavone daidzein, but equol supplements themselves may not have the same effects, says a new study.
There is no evidence that the probiotic strain Bifidobacterium breve can reduce the risk of necrotising enterocolitis (NEC), late-onset sepsis and death in preterm infants, a study of 1315 infants has found.
Since taking the European Food Safety Authority (EFSA) throne last summer, Dr Bernhard Url has become something of a pin-up boy for the so-called new ‘open EFSA’. But how far exactly is this new executive director willing to take his vision of transparency?
Long term intake of a high-dose resveratrol supplement or drug may help people with mild to moderate Alzheimer's disease to stabilise a biomarker that declines when the disease progresses, say researchers.